All articles tagged with #bronchiectasis
Originally Published 1 year ago — by Yahoo Finance
Insmed Incorporated's stock surged by up to 110% following positive study results for a drug treating bronchiectasis, a chronic lung condition. Analysts are optimistic about the company's future, with plans to file for U.S. market clearance and potential applications for other diseases.
Originally Published 1 year ago — by STAT
Insmed's experimental drug brensocatib successfully reduced lung problems in bronchiectasis patients during a Phase 3 trial, leading to a significant increase in the company's share price. Both tested dosages of the drug met the primary endpoint by reducing pulmonary exacerbations by about 20% compared to placebo, with analysts predicting potential billion-dollar annual sales if approved.
Originally Published 2 years ago — by OregonLive
Medicines should be stored in a cool, dark place as heat and sunlight can damage their effectiveness. Studies have shown that medicines sent by mail order can be exposed to temperatures outside their recommended range, potentially compromising their efficacy. Liquid medicines, hormones, and nitroglycerin are particularly sensitive, as well as medications that require precise dosing. It is recommended to use a local pharmacy if possible, but for those with mail-order prescriptions, requesting special packaging during warm weather or having them shipped to a temperature-controlled environment can help mitigate the risk. Additionally, weight loss is common in chronic lung diseases like bronchiectasis due to increased energy expenditure, medication side effects, poor appetite, inflammation, and potential depression. Dietary changes and maintaining muscle strength are important for managing weight loss in these conditions.
Originally Published 2 years ago — by Hindustan Times
The color of phlegm, also known as sputum, from patients with bronchiectasis, a long-term lung condition, may indicate the degree of inflammation in their lungs and predict their future outcomes, according to a study presented at the European Respiratory Society International Congress. The study, which included nearly 20,000 patients from 31 countries, found that sputum color can serve as a biomarker for inflammation and is associated with exacerbations, hospitalizations, and mortality. The findings suggest that monitoring sputum color could improve treatment and monitoring of bronchiectasis patients, empowering them to self-manage their condition.